A detailed history of Patten & Patten Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Patten & Patten Inc holds 16,270 shares of LLY stock, worth $12.7 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
16,270
Previous 16,428 0.96%
Holding current value
$12.7 Million
Previous $14.9 Million 3.09%
% of portfolio
1.01%
Previous 1.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $121,998 - $151,683
-158 Reduced 0.96%
16,270 $14.4 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $187,016 - $234,532
-258 Reduced 1.55%
16,428 $14.9 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $622,402 - $832,686
1,051 Added 6.72%
16,686 $13 Million
Q4 2023

Jan 23, 2024

SELL
$525.19 - $619.13 $973,177 - $1.15 Million
-1,853 Reduced 10.6%
15,635 $9.11 Million
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $219,958 - $303,245
506 Added 2.98%
17,488 $9.39 Million
Q2 2023

Jul 14, 2023

SELL
$350.74 - $468.98 $68,394 - $91,451
-195 Reduced 1.14%
16,982 $7.96 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $1.64 Million - $1.92 Million
5,266 Added 44.21%
17,177 $5.9 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $1.49 Million - $1.74 Million
4,631 Added 63.61%
11,911 $4.36 Million
Q3 2022

Oct 19, 2022

BUY
$296.48 - $337.87 $44,768 - $51,018
151 Added 2.12%
7,280 $2.35 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $215,737 - $253,306
774 Added 12.18%
7,129 $2.31 Million
Q1 2022

Apr 25, 2022

SELL
$234.69 - $291.66 $2,346 - $2,916
-10 Reduced 0.16%
6,355 $1.82 Million
Q4 2021

Jan 26, 2022

BUY
$224.85 - $279.04 $13,266 - $16,463
59 Added 0.94%
6,365 $1.76 Million
Q3 2021

Oct 22, 2021

BUY
$221.6 - $272.71 $1,994 - $2,454
9 Added 0.14%
6,306 $1.46 Million
Q2 2021

Jul 13, 2021

BUY
$180.55 - $233.54 $188,133 - $243,348
1,042 Added 19.83%
6,297 $1.45 Million
Q1 2021

Apr 23, 2021

SELL
$164.32 - $212.72 $187,817 - $243,138
-1,143 Reduced 17.86%
5,255 $982,000
Q4 2020

Jan 19, 2021

BUY
$130.46 - $172.63 $45,661 - $60,420
350 Added 5.79%
6,398 $1.08 Million
Q3 2020

Oct 08, 2020

SELL
$146.22 - $169.13 $23,980 - $27,737
-164 Reduced 2.64%
6,048 $895,000
Q2 2020

Jul 21, 2020

BUY
$136.42 - $164.18 $84,853 - $102,119
622 Added 11.13%
6,212 $1.02 Million
Q3 2019

Oct 15, 2019

BUY
$106.79 - $116.16 $37,483 - $40,772
351 Added 6.7%
5,590 $625,000
Q2 2019

Jul 11, 2019

SELL
$110.79 - $129.32 $5,539 - $6,466
-50 Reduced 0.95%
5,239 $580,000
Q1 2019

Apr 23, 2019

BUY
$111.31 - $131.02 $111 - $131
1 Added 0.02%
5,289 $686,000
Q3 2018

Oct 17, 2018

SELL
$85.86 - $107.31 $5,151 - $6,438
-60 Reduced 1.12%
5,288 $567,000
Q2 2018

Jul 18, 2018

SELL
$75.7 - $86.88 $113,550 - $130,320
-1,500 Reduced 21.9%
5,348 $456,000
Q1 2018

Apr 20, 2018

SELL
$74.21 - $87.6 $33,394 - $39,420
-450 Reduced 6.17%
6,848 $530,000
Q3 2017

Oct 12, 2017

BUY
$77.07 - $85.54 $562,456 - $624,270
7,298
7,298 $624,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.